Obesity is associated with disrupted reproductive cycles in mares, but the impact of obesity on follicles and oocytes has received minimal attention. We investigated the impact of obesity on 1) expression of selected genes in follicle cells for carbohydrate metabolism, inflammatory cytokines, lipid homeostasis, endoplasmic reticulum stress, and mitochondrial function; 2) follicular fluid content of metabolic hormones and metabolites; and 3) lipid fingerprint of oocytes. Mares (9-13 yr) were classified as control (n ¼ 8, normal weight, body condition score [BCS] 5.1, 10.4% body fat) or obese (n ¼ 9, BCS 7.9, 16.2% body fat). Gene expression from granulosa cells (GC) and cumulus cells (CC) was evaluated by RT-PCR. Serum and follicular fluid were evaluated for insulin, leptin, adiponectin, and metabolite profiling. Oocyte lipid fingerprints were acquired using matrixassisted laser desorption/ionization mass spectrometry. Several genes for lipid homeostasis, endoplasmic reticulum stress, and mitochondrial function were different between groups in GC and CC. Obese had (P , 0.05) or tended to have (0.05 , P , 0.1) lower insulin sensitivity and higher insulin and leptin in serum and follicular fluid. Many metabolites differed between control and obese in serum and/or follicular fluid and correlated with BCS and/or insulin sensitivity. Oocytes from control had greater concentrations of lipids consistent with phosphatidylcholines, phosphatidylethanolamines, and sphingomyelins, while lipids consistent with triglycerides tended to be higher in obese. These findings suggest that maternal obesity causes alterations in the follicle and oocyte; the extent to which these alterations impact the conceptus and offspring is still to be determined.
INTRODUCTION
Patterns of increasingly overweight and obese horses are similar to those observed in humans, with the prevalence varying from 20% to 62%, depending on management, geographic location, method of evaluation, and time of year [1] . In mares, obesity and insulin resistance are associated with altered estrous cycles [2] and development of anovulatory follicles [3] . Mares with equine metabolic syndrome have or tend to have elevated concentrations of insulin, leptin, interleukin 1b, and tumor necrosis factor-a as well as decreased adiponectin concentrations in follicular fluid that are strongly correlated to systemic concentrations [4] . However, the role of equine obesity on follicular function and the oocyte remains to be elucidated.
Obesity has a substantive impact on human reproduction. In the United States, nearly two-thirds of reproductive-age women are overweight or obese [5] [6] [7] , and the deleterious effects of obesity during pregnancy and on the newborn have been widely accepted [8] [9] [10] . Less is known regarding the effect of obesity on the oocyte, follicle, and early stages of gestation in the woman. The earliest stage at which elevated maternal weight can impact offspring health remains to be determined; however, paternal obesity has also been found to retard embryo development and metabolism [11] , indicating an effect of obesity on gametes.
In women, increased obesity is associated with decreased fertility related to anovulation [12] and reduced conception and pregnancy rates when ovulation does occur [13] . The mechanisms of decreased fertility are largely unknown and possibly multifactorial. However, there is evidence that oocyte competence is affected [14] . In women undergoing assisted reproductive techniques, increased obesity is associated with a significant rise in failure to achieve a clinical pregnancy with the use of autologous oocytes but not with donor oocytes, indicating that impaired oocyte quality is associated with obesity [14] . In mice, maternal obesity induced by diet results in adverse effects in the oocyte and preimplantation embryo. When compared to normal counterparts, the obese mice have larger offspring at delivery, with impaired glucose tolerance and increased cholesterol and body fat [15] .
Mares with equine metabolic syndrome have alterations in levels of cytokines and adipokines in follicular fluid [4] , which could alter oocyte viability, ovulation, or early programming in offspring. In women undergoing in vitro fertilization, failure of oocytes to cleave or result in successful pregnancy outcome is associated with altered follicular fluid concentrations of lactate, glucose, high-density lipoprotein (HDL), proline, leucine, and isoleucine [16] . Additionally, elevated free fatty acid concentrations in follicular fluid are associated with decreased oocyte maturation and fertilization rates and poor-quality embryos in cattle [17] , mice [18] , and humans [19] . This exposure to high follicular fluid lipid concentrations could impact oocyte competence and gene expression, similar to somatic cells. When exposed to a high lipid environment, lipotoxicity has been documented in hepatocytes, monocytes, and b-cells of the pancreas, resulting in damage to cellular organelles, including mitochondria and the endoplasmic reticulum (for review, see Malhotra and Kaufman [20] ).
Most research on the effect of obesity on fertility and offspring health has incorporated litter-bearing, rodent models, or it is based on clinical assisted fertilization in women who could have additional pathologies affecting fertility other than obesity. Minimal research has been conducted in this area on large or monovular species. For these reasons, we sought to determine the impact of obesity on the preovulatory follicle and in the lipid fingerprint of oocytes in mares. We tested the following hypotheses: 1) obese mares will have altered lipid homeostasis, endoplasmic reticulum stress, and impaired mitochondrial function as reflected in the gene expression of granulosa and cumulus cells; 2) systemic changes in metabolic hormones and metabolites will result in alterations in follicular fluid; and 3) lipid content will be altered in the oocytes of obese mares when compared to oocytes from mares of normal weight.
MATERIALS AND METHODS

Mare Management and Sample Collection
Samples were collected from nonlactating, light-horse mares aged between 9 and 13 yr (n ¼ 16) from mid-July to late August at 40.55928 N, 105.07818 W. All animal procedures were performed in accordance with the Institutional Animal Care and Use Committee at Colorado State University and the Society for the Study of Reproduction's guidelines and standards. Mares were divided into two groups based on existing body condition. Control mares (n ¼ 8) were fed grass hay, with more mares per hay feeder resulting in some restriction on ease of access; this allowed for maintenance of a normal body weight. Obese mares (n ¼ 8) were fed the same grass hay ad libitum as control mares, with fewer mares per feeder to allow easy access to hay. Obese mares were also supplemented with corn, 1.36 kg per mare daily, for 3 mo to achieve or maintain an obese body condition prior to sample collection (Table 1) . Obesity was determined using body condition scores (BCS) [21] and % body fat (%BF) as calculated from the equation based on fat thickness at 11 cm caudal and 10 cm lateral from midline at the tail head (%BF ¼ 2.47 þ [5.47 * (tail head fat in centimeters)]) [22] .
Mare reproductive tracts were examined using transrectal ultrasonography (Exago, Universal Medical Systems, New Bedford, NY; 5-MHz linear transducer). When a growing follicle !35 mm and uterine edema were observed during the follicular phase, a GnRH analog (deslorelin acetate, 1.5 mg, i.m.; Precision Pharmacy, Bakersfield, CA) was administered to induce follicle maturation. Between 22 and 24 h after administration of deslorelin, cumulus oocyte complexes, granulosa cells, and follicular fluid were collected by ultrasound-guided, transvaginal aspirations, as previously described [23] . At this time, oocytes are anticipated to be in the process of nuclear maturation, most likely at metaphase I, and all granulosa and cumulus cells were at a stage of expansion consistent with this based on visual assessment. For the collection of follicular fluid, the needle was positioned within the central area of the follicular antrum, and the sample of fluid was collected prior to total follicular collapse and blood contamination. Following identification of the cumulus oocyte complex, cumulus cells were gently removed by slicing with two 21-gauge needles. Cumulus cells were rinsed in phosphate buffered saline with 0.02% polyvinyl alcohol (Sigma, St. Louis, MO), homogenized in 600 ll of lysis buffer (RLT, Allprep DNA/RNA/Protein isolation kit; Qiagen, Valencia, CA), and then snap frozen in liquid nitrogen and stored at À808C until RT-PCR analysis. Granulosa cells were isolated from the follicular aspirate and processed as described for the cumulus cells. Oocytes were denuded of remaining cumulus cells by placing them in a commercially available benchtop medium (G-MOPS; Vitrolife AB, Göteborg, Sweden) with hyaluronidase (200 IU/ml; Sigma) for 8 min before mechanical removal of cumulus cells by gentle pipetting. Oocytes were carefully evaluated to confirm complete removal of cumulus cells, then fixed in a 50% methanol solution and stored at À808C until analysis by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF) to determine the comparative lipid fingerprint.
Blood was collected prior to the morning feeding of corn on aspiration days to determine concentrations of glucose (Accutrend Plus meter; Roche Diagnostics, Indianapolis, IN), insulin, leptin and adiponectin, insulin sensitivity, and metabolite analysis. Whole blood was allowed to clot for 2-4 h at 48C, centrifuged at 1500 3 g for 10 min, and then stored at À208C until analysis. Follicular fluid was centrifuged within 10 min after collection at 1500 3 g for 10 min and stored at À208C until analysis. Insulin resistance was determined using the reciprocal of the square root of insulin (RISQI; fasted insulin À0.5 ), a measure of insulin sensitivity, and modified insulin-to-glucose ratio (MIRG; 800 À 0.3 [fasted insulin À 50] 2 / [fasted glucose À 30]), a measure of pancreatic b-cell and insulin secretory responsiveness [24] .
Blood Sample and Follicular Fluid Analysis
A small aliquot from each serum and follicular fluid sample was removed. These small aliquots were combined into either a pooled serum or a follicular fluid sample to use for calculation of the intra-assay coefficients of variation. Concentrations of insulin were determined using a validated radioimmunoassay (RIA; Coat-A-Count; Siemens Healthcare, Erlangen, Germany) as previously reported in serum [25] and follicular fluid [4] . The intra-assay coefficient of variation of the pooled samples was 15.0%, and the limit of detection was 2.5 lIU/ml. Concentrations of leptin were determined according to the manufacturer's protocol using an RIA (Multi-Species Leptin RIA; Millipore Corp., Billerica, MA) previously validated for use in equine serum [26] and follicular fluid [4] . In the absence of purified equine leptin, results are expressed as human equivalents of immunoreactive leptin (leptin-HE). The intra-assay coefficient of variation of the assay was 11.0%. The limit of detection for the assay was 0.87 lIU/ml. Concentrations of adiponectin were determined according to the manufacturer's protocol using an RIA (Human Adiponectin RIA; Millipore) previously validated for use in equine plasma [27] and follicular fluid [4] . In the absence of purified equine adiponectin, results are expressed as human equivalents of immunoreactive adiponectin (adiponectin-HE). The intra-assay coefficient of variation of the assay was 5.7%, and the limit of detection was 1.7 lIU/ml.
Triglyceride concentrations in plasma were determined using a calorimetric assay kit (Cayman Chemicals, Ann Arbor, MI) according to the manufacturer's instructions. The 96-well microplate (Thermo Fisher Scientific, Waltham, MA) was read at 540-nm absorbance on a Synergy 2 plate reader (Biotek, Winooski, VT). The intra-assay coefficient of variation of the pooled samples was 0.9%, and the limit of detection was 3.1 mg/dl.
Concentrations of HDL and low-density lipoprotein (LDL)/very lowdensity lipoprotein (VLDL) cholesterol in serum were determined using a fluorometric HDL and LDL/VLDL Cholesterol Assay Kit (Cell Biolabs, Inc., 
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San Diego, CA) according to the manufacturer's instructions with the modification of the emission reading. The assay was read at an excitation of 540 nm and emission of 620 nm on a Synergy 2 plate reader. The intra-assay coefficient of variation of the pooled samples was 2.2%, and the limit of detection was 1.0 lM.
RNA Isolation, DNA Methylation, and Gene Expression
Total RNA and genomic DNA from cumulus and granulosa cells were isolated using the AllPrep RNA/DNA/Protein Kit per the manufacturer's instructions. Following isolation, the RNA fractions were treated with DNAse (Invitrogen, Carlsbad, CA) to prevent contamination with residual genomic DNA. Primers for the endogenous reference genes and genes relating to carbohydrate metabolism, inflammation, lipid homeostasis, endoplasmic reticulum (ER) stress, oxidative stress, mitochondrial stress, and the insulinlike growth factor (IGF) system were designed using predicted sequences for the horse (see Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). Complementary DNA was generated using the qScript cDNA synthesis kit (Quanta Bioscience, Gaithersburg, MD) with both oligo (dT) and random primers. Real-time PCR was performed using the LightCycler 480 II Real-Time PCR System and the LightCycler 480 SYBR Green I Master detection reagents (Roche Applied Science, Indianapolis, IN). For each sample, all genes were analyzed simultaneously in duplicate. Negative controls were included on every plate for every primer set. For granulosa cells, 12.5 ng of cDNA were used per reaction. All quantitative PCR (qPCR) reactions were run at 958 for 5 min, followed by 45 cycles of 958C for 10 sec, 608C for 30 sec, and 728C for 30 sec. For cumulus cells, due to lower mRNA abundance, only genes found to be different in granulosa cells and the IGF system were analyzed. Additionally, 1.5 ng of cDNA were used per reaction, and the cycle number for PCR increased to 55 cycles. Products of qPCR were analyzed on an agarose gel with ethidium bromide to confirm specificity based on fragment size. DNA was isolated from the gel (QAIquick PCR Purification Kit; Qiagen) and sequenced to confirm amplification of the genes of interest (DNA Sequencing Facility, University of California, Davis). Data were analyzed using the LightCycler 480 Relative Quantification Software (Roche Applied Science) and normalized to the geometric mean of the two endogenous controls (tubulin and glyceraldehyde 3-phosphate dehydrogenase). Melting curves for each sample were analyzed to validate specificity of amplification.
Isolated genomic DNA from granulosa cells were used for global DNA methylation. Cumulus cells did not yield enough DNA for evaluation. Analysis was completed using the MethylFlash Methylated DNA Quantification kit (Epigentek, Farmingdale, NY) according to the manufacturer's instructions, including a supplied methylated polynucleotide containing 50% of 5-methylcytosine (positive control) and an unmethylated polynucleotide containing 50% of cytosine (negative control).
The ME3 negative control is an unmethylated polynucleotide containing 50% of cytosine. The ME4 positive control is a methylated polynucleotide containing 50% of 5-methylcytosine. Assays were read on a Victor X5 plate reader (Perkin-Elmer, Waltham, MA) at 450-nm absorbance.
Metabolite Extraction and Detection Using Gas and Liquid Chromatography Coupled to Mass Spectrometry (GC-and LC-MS)
Metabolites were extracted by adding 800 ll of LC-MS-grade methanol to 200 ll of serum or follicular fluid. Samples were incubated at À208C for 2 h and centrifuged at 13 000 3 g at 48C for 30 min. For GC-MS, 400 ll of extract were dried using a speedvac, resuspended in 50 ll of pyridine containing 15 mg/ml of methoxyamine hydrochloride, incubated at 608C for 45 min, bath sonicated for 10 min, and incubated for an additional 45 min at 608C. Next, 50 ll of N-methyl-N-trimethylsilyltrifluoroacetamide with 1% trimethylchlorosilane (MSTFA þ 1% TMCS; Thermo Scientific) were added. Then samples were incubated at 608C for 30 min, centrifuged at 3000 3 g for 5 min, and cooled to room temperature before 80 ll of the supernatant were transferred into a 150-ll glass insert in a GC-MS autosampler vial. Metabolites were detected using a Trace GC Ultra coupled to a Thermo DSQ II mass spectrometer (Thermo Scientific). Samples were injected in a 1:10 split ratio twice in discrete randomized blocks. Separation occurred using a 30-m TG-5MS column (Thermo Scientific; 0.25-mm i.d., 0.25-lm film thickness) with a 1.2-ml/min helium gas flow rate, and the program consisted of 808C for 30 sec, a ramp of 158C/min to 3308C, and an 8-min hold. Masses between 50 and 650 m/z were scanned at five scans per second after electron impact ionization.
For LC-MS, 1 ll of metabolite extract was injected twice (n ¼ 2 replicates) onto a Waters Acquity UPLC system in discrete, randomized blocks and separated using a Waters Acquity UPLC T3 column (1.8 lM, 1.0 3 100 mm), using a gradient from solvent A (water, 0.1% formic acid) to solvent B (acetonitrile, 0.1% formic acid). Injections were made in 100% A, held at 100% A for 1 min, followed by a linear gradient to 95% B in 12 min, held at 95% B for 3 min, returned to starting conditions over 0.05 min, and allowed to reequilibrate for 3.95 min with a 200-ll/min flow rate. The column and samples were held at 508C and 58C, respectively. The column eluent was infused into a Waters Xevo G2 Q-TOF-MS with an electrospray source in positive mode, scanning 50-1200 m/z at 0.2 sec per scan, alternating between MS (6-V collision energy) and MSE mode (15-to 30-V ramp). Calibration was performed using sodium formate with 1-ppm mass accuracy. The capillary voltage was held at 2200 V, source temperature at 1508C, and nitrogen desolvation temperature at 3508C with a flow rate of 800 L/h.
For each sample, raw data files were converted to CDF format, and a matrix of molecular features, as defined by retention time and mass (m/z), was generated using XCMS software in R [28] for feature detection and alignment. Raw peak areas were normalized to total ion signal in R, outlier injections were detected based on total signal and PC1 of principal component analysis, and the mean area of the chromatographic peak was calculated among replicate injections (n ¼ 2). Features were grouped based on coelution and covariation in the data set [29, 30] to annotate compounds based on retention time and/or spectral matching to in-house, NIST v11 and v12, Golm, Metlin, and Massbank metabolite databases.
Lipid Fingerprinting of Oocytes Using MALDI-TOF-MS
Oocytes were evaluated for lipid content using MALDI-TOF-MS as described previously [31] . Briefly, oocytes were taken directly from the storage methanol solution, spotted on an MTP 384 stainless-steel MALDI target plate (Bruker Daltonics, Bremen, Germany), and allowed to dry. Dried oocytes were layered with 1 ll of 2,5-dihydroxybenzoic acid (DHB; 10 mg/ml in 50% acetonitrile, 0.1% trifluoracetic acid) prior to analysis. Mass spectra were acquired using a Bruker Ultraflex II MALDI-TOF/TOF (Bruker Daltonics) in positive ion reflector mode with a 25-kV acceleration voltage, using a mass window of 700-3440 m/z. External calibration was performed using the Bruker peptide calibration standard II that was cospotted with DHB matrix. Each oocyte was analyzed until no further data could be collected without dramatically increasing the laser power. Subsets of the most abundant masses identified in the MS spectrum were subjected to MS/MS analysis using the same instrument in LIFT mode. The same samples were used for this analysis as were used for the MS/MS analysis, but higher laser powers were used in order to account for the sample loss that occurred during MS data collection.
Peak detection, alignment, and quantitation in the MS data were performed using XCMS software in R [28] . Peak intensities were normalized using the total ion current (TIC) for the spectrum. Briefly, the areas of each peak identified in a single sample were summed to estimate the TIC. The mean TIC value across all samples was then used to produce a scaling factor for each sample by dividing the sample TIC by the calculated mean TIC across all samples. All peak areas in the sample were then divided by this scaling factor to give normalized peak areas. Potential lipid identifications for the observed spectral peaks were determined by comparing the high mass-accuracy MS data and/or the LIFT mode-collected MS/MS data to previously published work [32] [33] [34] [35] [36] [37] .
Statistics
Data are expressed as mean 6 SEM. Differences between insulin sensitivity, insulin, leptin, adiponectin, triglycerides, and cholesterol were determined using Student t-tests (SigmaPlot 11.0; Systat Software Inc., Chicago, IL). Relative gene expression in granulosa and cumulus cells and DNA methylation in granulosa cells were first analyzed using the Grubb test for determination of outliers (Graphpad Software Inc., La Jolla, CA). Outliers were removed, and data that failed the Shapiro-Wilk normality test or equal variance test were log-transformed to normalize the data set prior to analysis using a Student t-test (SigmaPlot). Serum and follicular fluid metabolites were evaluated based on molecular features that differed (Student t-test; Excel, Redmond, WA) among ion abundances between control and obese. Metabolites were also correlated to body composition, body fat, or insulin sensitivity (0.44 , Spearman r s , À0.44) using the ''cor'' function in R (R Development Core Team 2012; http://www.r-project.org). Normalized peak areas for oocyte lipids were compared using a Student t-test (Excel). Differences were considered to be highly significant at P , 0.05 and tending toward significance at P ! 0.05 and P 0.1.
OBESITY AFFECTS FOLLICLE MILIEU AND OOCYTE LIPIDS
RESULTS
Insulin Sensitivity, Metabolic Hormones, and Triglyceride and Cholesterol Analysis
Control maintained BCS and BF throughout the duration of the study, while obese increased BCS by 0.60 and BF by 3%. At the time of follicle collection, control had 7.5% lower (P , 0.05) body fat and decreased (P , 0.05) BCS than obese (Table 1) . Control RISQI scores tended to be higher at P ¼ 0.1, indicative of higher insulin sensitivity, and lower MIRG scores (P , 0.09), indicating more pancreatic b-cell and insulin secretory responsiveness (Table 1 ). In obese, systemic concentrations of insulin tended (P ¼ 0.06) to be elevated, while follicular fluid concentrations were significantly higher (P , 0.01; Fig. 1A ). Both systemic and follicular fluid concentrations of leptin were higher in obese (P , 0.001; Fig.  1B ), although concentrations of adiponectin did not differ (Fig.  1C) . Serum and follicular fluid concentrations were positively correlated for insulin (r 2 ¼ 0.69, P , 0.01), leptin (r 2 ¼ 0.85, P , 0.001), and adiponectin (r 2 ¼ 0.62, P , 0.01). Triglyceride concentrations in plasma and follicular fluid tended (P , 0.1) to be higher in obese than control ( Fig. 2A) , and obese tended (P , 0.1) to have elevated HDL and total cholesterol in follicular fluid, although serum concentrations of HDL, LDL/VLDL, and total cholesterol were similar (Fig. 2B) .
Gene Expression and DNA Methylation
In granulosa cells, gene expression between control and obese was similar for the studied genes associated with carbohydrate metabolism or inflammatory cytokines and their receptors (Table 2) . However, granulosa cells from obese had altered expressions of some genes encoding for proteins involved in lipid homeostasis, ER stress and the unfolded protein response, oxidative stress, and mitochondrial function. Granulosa cells from obese also had elevated expression of some genes within the IGF system (Table 2) .
Gene expression in cumulus cells did not strictly correspond with the same genes in granulosa cells (Table 3) . Trends for gene expression for the IGF system were in contrast to 
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TABLE 2. Relative gene expression in granulosa cells from control and obese with rows in bold indicating differences of P 0.1
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granulosa cells, and expression of IGFBP3 was undetectable in the cumulus cells of most mares at the concentrations of cDNA analyzed. Global DNA methylation, as determined by measuring levels of 5-methylcytosine (5-mC), was 35% higher in granulosa cells from obese compared to control (P ¼ 0.03; Fig. 3 ).
Metabolite Variation
Approximately 16 000 molecular features, defined by mass (m/z), chromatography elution time, and relative abundance, were detected in the serum and follicular fluid metabolomics data set. The molecular features were annotated based on MS matching to in-house and external MS databases and characterized 93 metabolites that included amines, amino acids, phospholipids, sterols, peptides, and unknowns (see Supplemental Table S2 ). A total of 43 metabolites varied in either the follicular fluid or serum data sets between control and obese (Fig. 4) . In obese, follicular fluid had a reduced relative abundance of several amines, including creatinine (P , 0.05), ornithine (P , 0.05), and four amino acids: phenylalanine (P , 0.05), arginine (P , 0.1), histidine (P , 0.1), and glutamate (P , 0.1). Obese also had a reduced quantity of several oxylipids in follicular fluid; however, concentrations of linoleic (P , 0.05) and stearic (P , 0.1) acids were elevated. Progesterone and hydroxyprogesterone were reduced (P , 0.05) in the follicular fluid of obese when compared to control. Additionally, 61 metabolites in serum and/or follicular fluid were correlated to BCS, %BF, or insulin resistance and insulin secretory response to glucose (Fig. 5) . Several lipids were decreased in both serum and follicular fluid in obese; overall, many of the metabolites that were correlated to body condition were consistent between serum and follicular fluid (Figs. 4B and 5B).
Oocyte Lipid Fingerprint
Analysis with MALDI-MS revealed that 38 of the spectral peaks representative of lipids differed between control and obese at P , 0.1 (Fig. 6 ). Oocytes from control had (P , 0.1) greater concentrations of lipids with spectral peaks of 700-850 m/z, consistent with phosphatidylcholines, phosphatidylethanolamines, and sphingomyelins, which are lipids involved in cellular membranes and structure (Table 4) . Oocytes from obese had (P , 0.1) higher concentrations of lipids with spectral peaks of 850-950 m/z consistent with triglycerides that are involved in energy metabolism.
DISCUSSION
Obesity is associated with reduced fertility, complications during pregnancy, and reduced fetal viability in the woman [38] . Complications of maternal obesity during pregnancy are more related to pregravid weight than gestational weight gain or weight at delivery [38] . The effect of obesity on the ovarian follicle and oocyte is not well defined in monovular species. In the present study, we demonstrated that the preovulatory follicle is impacted by maternal adiposity, with maternal weight affecting both the follicular environment and the oocyte.
Alterations observed in our study were consistent with those expected with increased body fat, including decreased sensitivity to insulin and decreased insulin secretory responsiveness. Increased obesity in mares was also associated with higher insulin and leptin concentrations in follicular fluid and serum, consistent with those observed for obese women [39, 40] and confirming that similar changes occur in both species with obesity. As in women [37] , serum and follicular fluid concentrations of insulin and leptin in mares were strongly correlated, suggesting that serum can be used as an indicator of follicular alterations.
Altered concentrations of insulin and leptin in follicular fluid could influence follicle function and oocyte competence. After exposure of granulosa cells to elevated insulin in vitro, cells from cattle and pigs have increased cell proliferation and/ or DNA synthesis [41, 42] , and cells from women have increased steroidogenesis [43] , indicating that elevated follicular insulin affects follicular function. In women undergoing in vitro fertilization, lower follicular fluid leptin concentrations are a marker for successful assisted reproductive success, and serum and follicular fluid concentrations are highly correlated (r 2 ¼ 0.83, P , 0.001) [41] , as we observed in the mare (r 2 ¼ 0.85). The increases in follicular fluid triglyceride concentrations in obese were consistent with increased triglycerides in the follicles of women [39] . Lipid-rich follicular fluid is associated with ER stress and impaired oocyte maturation in mice [44] , but similar studies have not been done in other large animal species or women.
Various metabolites were different in follicular fluid from control and obese. Of particular interest were linoleic and stearic acids, which were higher in obese. Linoleic acid is an important essential, long-chain, unsaturated fatty acid that is a precursor for prostaglandin E 2 synthesis, which is necessary for oocyte maturation and ovulation [45, 46] . However, exposure to a high but physiological, concentration (100 lM) of linoleic acid in vitro results in increased cytoplasmic lipid droplets and lower maturation rates for bovine oocytes [47] . Decreasing linoleic acid in follicular fluid could be necessary for germinal vesicle breakdown in bovine oocytes [48] . Additionally, supplementation with 100 lM linoleic acid inhibits glutathione peroxidase (GPX1) expression and limits nuclear maturation, in part due to reduced mitochondrial activity associated with increased reactive oxygen species in bovine cumulus oocyte complexes [49] . As GPX1 is a selenium-dependent, reactive oxygen species scavenging enzyme that can reduce both H 2 O 2 and organic peroxides to water and alcohol, it is critical for protection against oxidative stress [50] . In our study, follicles with elevated linoleic acid in follicular fluid had lower GPX1 expression in granulosa cells and elevated triglycerides in oocytes. Stearic acid was another fatty acid that tended to be elevated in the follicular fluid of obese. Stearic acid has been 
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implicated in ovarian dysfunction in high-yield dairy cows by inhibiting granulosa cell proliferation and inducing apoptosis [51] . Human granulosa cells exposed to stearic acid have doseand time-dependent decreases in cell survival, caused by increased apoptosis [52] .
Several of the metabolite trends, especially associated with fatty acids and glycero-and oxylipids, were similar in serum and follicular fluid; therefore, serum could potentially be used to screen for follicular alterations in these metabolites. Ultimately, serum markers that correlate with follicular function would be a valuable tool to assess the potential of an individual's body weight to impact reproduction.
Oocyte lipid content was altered with obesity in mares. The lipid fingerprint of individual cells can be determined with MALDI-MS [53] , and it has been used to compare lipid fingerprints of oocytes between species and to evaluate bovine embryos after culture [31] . To our knowledge, this is the first study to use MALDI-MS to identify differences in oocyte lipids caused by maternal obesity. Control oocytes had an elevated relative abundance of several phospholipids. As phospholipid composition determines most physiochemical cell membrane properties [54] , oocytes from control and obese could differ in fluidity and permeability of the oolemma. In addition, oocytes from Obese had elevated relative abundance 
of seven triglycerides, with most of the triglycerides containing linoleic and/or stearic acid. These fatty acids could have been incorporated from follicular fluid, as has been described for bovine oocytes when linoleic acid was supplemented during culture of cumulus oocyte complexes [47] . While this increase in intracellular triglyceride could be beneficial for cryotolerance [47] and provide increased energy substrates, the excess lipid could lead to ER stress, decreased mitochondrial function, and lipotoxicity [18] . We considered if the dietary corn was partially responsible for the altered oocyte lipid fingerprints. However, oocytes collected from normal weight mares (n ¼ 3) and obese mares (n ¼ 2) during a later study in which all mares were fed only hay had oocyte lipid fingerprints that were consistent with those in the present study (data not shown).
Granulosa and cumulus cell gene expression was evaluated for markers of carbohydrate metabolism, lipid homeostasis, ER stress, oxidative stress, mitochondrial stress, and the IGF system. Genes for carbohydrate metabolism and inflammation were similarly expressed. However, granulosa cells from obese demonstrated altered expression for some genes involved in lipid homeostasis, ER and mitochondrial stress, and the IGF system.
Two of the genes involved in lipid homeostasis that were altered in obese were perilipin-2 (PLIN2) and scavenger receptor B1 (SCARB1). PLIN2 stimulates the accumulation of lipid droplets and is upregulated in mouse oocytes after hCG stimulation [55] . Granulosa cells of obese had decreased expression, and cumulus cells had increased expression of PLIN2. Increased PLIN2 in cumulus cells of obese could have impacted the increased triglyceride concentrations in their oocytes. Scavenger receptor B1 promotes cellular uptake of high-density lipoprotein (HDL), which is then either packaged into lipid droplets or acted on by hormone-sensitive natural lipases; then the free cholesterol is either re-esterified for storage or transported into the mitochondria for steroid synthesis [56] . Cholesterol is converted into pregnenolone, which is exported from mitochondria and converted into other compounds, including progesterone, by the ER (for review, see Ramalho-Santos and Amaral [57] ). Therefore, mitochondrial and endoplasmic function is crucial to steroidogenesis and follicular function. Steroidogenic granulosa cells are able to evade cholesterol homeostatic control through SCARB1 in order to take up sufficient cholesterol for steroid production [58] . Potentially, the elevated HDL observed in obese resulted in an increase of expression of SCARB1 to facilitate cellular uptake of follicular fluid cholesterol and to compensate for the decreased progesterone and hydroxyprogesterone in the follicular fluid.
In mice, lipid accumulation in cumulus oocyte complexes due to high-fat diets [18] or exposure to lipid-rich follicular fluid [44] increased the expression of genes related to ER stress. Endoplasmic reticulum stress leads to impairment of oocyte maturation, mitochondrial potential, and embryo development [59] . Two genes, indicative of ER stress and the unfolded protein response, were upregulated in obese: eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) and heat shock 70-kDa protein 5 (HSPA5), also known as 78-kDa glucose-regulated protein, or GRP-78. In cultured 3T3-L1 adipocytes and in in vivo subcutaneous human adipose tissue, elevated insulin is responsible for an increase in the unfolded protein response, most likely due to the ability of insulin to increase protein synthesis [60] . The upregulation of EIF2AK3 and HSPA5 could be in response to elevated insulin and indicate ER stress in obese.
In addition to ER stress, mitochondrial dysfunction is observed in cumulus oocyte complexes from mice fed a highfat diet [18] . Two mitochondrial enzymes had reduced expression in granulosa cells of obese: peroxiredoxin-3 (PRDX3) and aldehyde dehydrogenase 4 family, member A1 (ALDH4A1). PRDX3 is a mitochondrial specific antioxidant enzyme that provides a major line of defense against mitochondrial reactive oxygen species, and depletion of PRDX3 in cells results in increased H 2 O 2 in mitochondria and eventually apoptosis [61] .
Obese had higher expression of IGFR1 in granulosa cells than control mares. The IGF system in equine follicle is known to play a role during deviation and dominant follicle selection [62] ; however, its role in follicular maturation is not known. In human granulosa cells, IGF1 stimulates DNA synthesis and basal estradiol secretion, while IGF2 stimulates basal estradiol and progesterone secretion (for review, see Poretsky et al. [63] ). The effects of IGF2 are more pronounced when cells are preincubated with insulin due to insulin-induced upregulation of type 1 IGF receptors (IGFR1), which is consistent with our findings. Although we are unsure of the mechanisms, mare weight affected the IGF system, with increased expression of IGF2, IGFR1, and IGFBP3 in granulosa cells and decreased DNA methylation is an important epigenetic event, and altered methylation has been linked to many disease states and impaired DNA repair [64] . Weight-associated alterations in global DNA methylation have not been examined in the horse. In human offspring, maternal nutritional status during early pregnancy results in persistent and systemic epigenetic changes at metastable epialleles [65] . Obesity has resulted in changes of DNA methylation in blood leukocytes of humans [60] and in adipose and muscle tissues of pigs [66] . Potentially, DNA methylation could be influenced by both obesity and decreased insulin sensitivity. In a matched monozygotic twin study, twins with insulin resistance have elevated global DNA methylation in leukocytes [67] . We found global DNA methylation to be 35% higher in granulosa cells from obese than control. Although we did not determine if genes of interest in this particular study were affected, our initial screening suggests that obesity is causing an alteration in DNA methylation in the follicle, and further study is warranted.
The decrease in progesterone and hydroxyprogesterone in obese warrants further investigation. It is unknown if concentrations were decreased due to a decline in the function of mitochondria and the ER or if there were disruptions in enzymes involved in the conversion of cholesterol to progesterone and hydroxyprogesterone, such as steroid acute regulatory protein (StAR). Previous analysis of StAR revealed no difference in gene expression between normal mares and those with equine metabolic syndrome [4] . However, it is possible that differences is StAR could occur from increases in overall adiposity rather than metabolic dysfunction.
In conclusion, we demonstrated that adiposity is sufficient to alter preovulatory follicular fluid composition, oocyte lipid content, and gene expression in granulosa and cumulus cells. When compared to mares of a normal weight (control), the increased content of linoleic and stearic acids and insulin in follicular fluid from obese could be contributing to ER stress in granulosa cells, as evidenced by elevated gene expression of EIF2AK3 and HSPA5, and to mitochondrial stress, as indicated by decreased expression of PRDX3 and ALDH4A1. This could * Rows in bold indicate P , 0.05; all others tend to be different (P 0.1). PA, phosphatidic acid (diacylglycerophospholipid); PC, glycerophosphocholine; PE, glycerophosphoethanolamine; PI, phosphatidylinositol; PG, phosphatidylglycerol; PS, phosphatidylserine; L, linoleic acid; O, oleic acid; P, palmitic acid; S, stearic acid; SM, sphingomyelin; Ln, linolenic; A, arachidc; MGDG, monogalatosyldiacylglycerol; TG, triacyglycerol; Cer, ceramide, O-, ester.
potentially lead to decreased capacity for progesterone production and altered cellular function. It remains to be elucidated if the decreased phospholipid and increased triglyceride content of oocytes from obese results in changes to membrane fluidity or ER stress in the oocytes or resulting embryos. However, these findings do suggest that maternal obesity causes alterations in the follicle and oocyte; the extent to which these alterations impact the conceptus and offspring is still to be determined.
